Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain (Q40161979)

18 September 2017

Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain (English)

1 reference

18 September 2017

Ming-Shyue Lee

1

1 reference

18 September 2017

Ming-Shyue Lee

2

1 reference

18 September 2017

I-Chu Tseng

3

1 reference

18 September 2017

Youhong Wang

4

1 reference

18 September 2017

Ken-ichi Kiyomiya

5

1 reference

18 September 2017

Michael D Johnson

6

1 reference

18 September 2017

Robert B Dickson

7

1 reference

18 September 2017

Chen-Yong Lin

8

1 reference

18 September 2017

7 March 2007

1 reference

American Journal of Physiology - Cell Physiology

18 September 2017

1 reference

18 September 2017

293

1 reference

18 September 2017

1

1 reference

18 September 2017

C95-105

1 reference

Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25).

18 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Deregulated activation of matriptase in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Gene expression profiling identifies matriptase overexpression in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Addition of 1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

The epidermal barrier function is dependent on the serine protease CAP1/Prss8

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Characterization of matriptase expression in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

The Activation of Matriptase Requires Its Noncatalytic Domains, Serine Protease Domain, and Its Cognate Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

The novel serine protease tumor‐associated differentially expressed gene–15 (matriptase/MT‐SP1) is highly overexpressed in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Direct measurement of trans-Golgi pH in living cells and regulation by second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Type II transmembrane serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): expression and prognostic value in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00611.2006

10.1152/AJPCELL.00611.2006

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference